Table 2 Disease activity measures
From: Characterizing lupus in African American children in Southern United States
Clinical Features | Study cohort (n = 45) | 1000 faces of lupus cohort (n = 213) | Chi-square test | Unpaired t-test |
|---|---|---|---|---|
ACR criteria | 5.1 (1.27) | NA | ||
SLEDAI at baseline | 13.06 (9.3) | 3.1 (2.1) | p < 0.0001 | |
SLEDAI at 6 months | 7.4 (6.81) | NA | ||
SLEDAI at 1 year | 4.7 (3.94) | NA | ||
SDI > 0* | 23 (51) | 32 (16) | 25.79, p < 0.00001 | |
SDI > 2* | 20 (44) | 14 (7) | 42.82, p < 0.00001 | |
Renal Involvement | 14 (31) | 72 (36) | 0.12, p = 0.72 | |
Neurologic Involvement | 9 (20) | 26 (13) | 1.92, p = 0.16 |